Search research articles
Contact Us
Filters
Showing results (11-20 of 173) with videos related to
Page
of 18
Sort By:
Therapeutics and Clinical Risk Management
|
June 6, 2015
New developments in the management of severe skin and deep skin structure infections - focus on tedizolid
Michael J Durkin, G Ralph Corey
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 28, 2008
Epidemiology of methicillin-resistant Staphylococcus aureus
Helen W Boucher, G Ralph Corey
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 10, 2015
Reply to Solnick
G Ralph Corey, Martin E Stryjewski
Expert Review of Anti-Infective Therapy
|
April 4, 2007
Daptomycin: a rapidly bactericidal lipopeptide for the treatment of Gram-positive infections
Zeina A Kanafani, G Ralph Corey
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 9, 2014
Editorial commentary: NOVA score to predict endocarditis in patients with enterococcal bacteremia: sticking to valves or to scores?
Martin E Stryjewski, G Ralph Corey
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 21, 2012
Ceftaroline applications for therapy in the United States
G Ralph Corey, Ronald N Jones
Journal of Biopharmaceutical Statistics
|
June 2, 2012
On the independence of data monitoring committee in adaptive design clinical trials
Shein-Chung Chow, Ralph Corey, Min Lin
Annals of Internal Medicine
|
March 22, 2006
Telithromycin
Michelle Turner, G Ralph Corey, Elias Abrutyn
The New England Journal of Medicine
|
September 23, 2014
Dalbavancin or oritavancin for skin infections
G Ralph Corey, Hai Jiang, Greg Moeck
Open Forum Infectious Diseases
|
October 24, 2018
Safety of Delafloxacin: Focus on Adverse Events of Special Interest
Thomas Lodise, Ralph Corey, David Hooper, et al.
Page
of 18
Search research articles
Search
Showing results (11-20 of 173) with videos related to
Sort By:
Page
of 18
Therapeutics and Clinical Risk Management
|
June 6, 2015
New developments in the management of severe skin and deep skin structure infections - focus on tedizolid
Michael J Durkin, G Ralph Corey
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 28, 2008
Epidemiology of methicillin-resistant Staphylococcus aureus
Helen W Boucher, G Ralph Corey
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 10, 2015
Reply to Solnick
G Ralph Corey, Martin E Stryjewski
Expert Review of Anti-Infective Therapy
|
April 4, 2007
Daptomycin: a rapidly bactericidal lipopeptide for the treatment of Gram-positive infections
Zeina A Kanafani, G Ralph Corey
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 9, 2014
Editorial commentary: NOVA score to predict endocarditis in patients with enterococcal bacteremia: sticking to valves or to scores?
Martin E Stryjewski, G Ralph Corey
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 21, 2012
Ceftaroline applications for therapy in the United States
G Ralph Corey, Ronald N Jones
Journal of Biopharmaceutical Statistics
|
June 2, 2012
On the independence of data monitoring committee in adaptive design clinical trials
Shein-Chung Chow, Ralph Corey, Min Lin
Annals of Internal Medicine
|
March 22, 2006
Telithromycin
Michelle Turner, G Ralph Corey, Elias Abrutyn
The New England Journal of Medicine
|
September 23, 2014
Dalbavancin or oritavancin for skin infections
G Ralph Corey, Hai Jiang, Greg Moeck
Open Forum Infectious Diseases
|
October 24, 2018
Safety of Delafloxacin: Focus on Adverse Events of Special Interest
Thomas Lodise, Ralph Corey, David Hooper, et al.
Page
of 18